William D. McCombe - 18 Nov 2025 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Nov 2025, 19:03:31 UTC
Prior SEC filing
20 Aug 2025
Next SEC filing
12 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Valerie Barnett, Attorney-in-Fact

Key filing fact

William D. McCombe filed Form 4 for Cytek Biosciences, Inc. (CTKB) on 20 Nov 2025.

Key facts

  • This page summarizes William D. McCombe's Form 4 filing for Cytek Biosciences, Inc. (CTKB).
  • 6 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 20 Nov 2025, 19:03.

Change

  • Previous filing in this sequence was filed on 20 Aug 2025.
  • Current net transaction value: -$34,441.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001878824 Primary reporting owner

McCombe William D.

Relationship
Chief Financial Officer
Address
C/O CYTEK BIOSCIENCES, INC., 47215 LAKEVIEW BOULEVARD, FREMONT
Signature
/s/ Valerie Barnett, Attorney-in-Fact
Signature date
20 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CTKB transaction

Common Stock

Options Exercise

Transaction value
Shares
+6,320
Change %
+9.4%
Price
Shares after
73,891
Date
18 Nov 2025
Ownership
Direct
Footnotes
F1
CTKB transaction

Common Stock

Tax liability

Transaction value
$11,237
Shares
-2,032
Change %
-2.7%
Price
$5.53
Shares after
71,859
Date
18 Nov 2025
Ownership
Direct
Footnotes
F2
CTKB transaction

Common Stock

Options Exercise

Transaction value
Shares
+13,051
Change %
+18%
Price
Shares after
84,910
Date
18 Nov 2025
Ownership
Direct
Footnotes
F1
CTKB transaction

Common Stock

Tax liability

Transaction value
$23,204
Shares
-4,196
Change %
-4.9%
Price
$5.53
Shares after
80,714
Date
18 Nov 2025
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CTKB transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-6,320
Change %
-9.1%
Price
$0.000000
Shares after
63,209
Date
18 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,320
Exercise price
Footnotes
F1, F3
CTKB transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-13,051
Change %
-7%
Price
$0.000000
Shares after
174,014
Date
18 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
13,051
Exercise price
Footnotes
F1, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.

Footnote F2

Represents the number of shares withheld by and surrendered to the Issuer on November 18, 2025, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.

Footnote F3

The shares subject to the RSU Award shall vest over 4 years with 12/48 of the total shares underlying the RSU Award vesting on May 18, 2025; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 3/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter; and 3/48 of the total shares underlying the RSU Award vesting on May 18, 2026 and each May 18 thereafter.

Footnote F4

The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter, until fully vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .